DeviceTalks Tuesdays Archives - Medical Design Sourcing

See what’s next from surgical robotics leaders on DeviceTalks Tuesdays

The FDA’s clearance of Intuitive’s Da Vinci 5 Surgical system will certainly be felt across a surgical robotics sector that’s already making great gains in securing FDA nods and building markets outside the U.S.

To provide a deeper look into some of the higher-profile surgical robotics companies, our DeviceTalks Tuesdays webinar series next week will stretch its traditional one-day format over three days, giving time and attention to three high-profile surgical robotics companies, including Intuitive.

Attendees to the event will get an inside look at how these companies view their place in the OR today and in the future.

DeviceTalks Tuesdays registration is free. Viewers watching live will be able to submit questions. On-demand viewing is available but questions won’t be allowed.

All sessions start at 12 p.m. Eastern time (9 a.m. Pacific time). Here is the lineup.

On Tuesday, March 19, Kathryn Rieger, PhD, senior director of human factors a…

Here’s how you achieve proactive product development

Use strategic collaboration to overcome these five common medtech product development challenges.

Overcoming product-development barriers — the topic of a recent Device Talks Tuesdays webinar sponsored by Celestica — requires the elimination of design silos and the embracement of partnering opportunities. So how does this happen? Kevin Walsh, VP of Celestica’s HealthTech Division, and Kevin McFarlin, engineering director, had some answers.

“It’s all about protecting and nurturing a company’s intellectual property in order to get to market as soon as possible,” Walsh said.

As a service provider for OEMs and startups, “we’re looking to mistake-proof the manufacturing and assembly processes,” added McFarlin, who outlined five common product design challenges and strategies for overcoming them.

1. Usability engineering: Establish priorities

Stressing the criticality of a medical device’s ease of use, Walsh emphasized that it is fundamental to widespread adop…

Keys to protecting your medtech AI from competitors

AI is a hot area in medtech. A panel of intellectual property experts had advice on protecting the IP.

DeviceTalks

[Image from Pixabay]

Between 2002 and 2019, annual AI patent applications more than doubled, and AI patent applications increased from 9% of all patent applications to 16%. AI is a white-hot area for investment and creation of valuable intellectual property, including artificial intelligence related to medical devices.

Protecting medical device-related AI was the topic of a recent episode of MassDevice and Medical Design & Outsourcing’s DeviceTalks Tuesdays, sponsored by Finnegan, a law firm that handles all aspects of IP.

The discussion involved Anthony Del Monaco and Cecilia Sanabria, both partners at Finnegan, and two CEOs of healthcare companies that have developed exciting AI-related IP: Jan De Backer, CEO of Fluidda, a respiratory imaging company, and Todd Usen, CEO o…

How Stryker is using 3D printing to advance orthopedics

Orthopedic device giant Stryker uses additive manufacturing to make porous geometries that wouldn’t otherwise be possible

DeviceTalks

3D printing, also called additive manufacturing, provides the ability to create new products and designs that are incredibly complex and hard to machine. For 20 years, Stryker has been on a journey to use additive manufacturing specifically to produce complex orthopedic implants. As a result, the company has made great strides when it comes to the way that orthopedic implants are designed and produced.

On a recent episode of our DeviceTalks Tuesdays webinar — sponsored by GE Additive, Foster, and Siemens — Stryker executive Naomi Murray detailed the company’s two-decade additive manufacturing journey. Murray, the company’s director of advanced operations for additive technology, described how innovations utilizing 3D printing make healthcare better.

Go to our sister site Medical Design & Outsourcing to read four takeaw…

How Stryker is using 3D printing to advance orthopedics

Orthopedic device giant Stryker uses additive manufacturing to make porous geometries that wouldn’t otherwise be possible

DeviceTalks

3D printing, also called additive manufacturing, provides the ability to create new products and designs that are incredibly complex and hard to machine. For 20 years, Stryker has been on a journey to use additive manufacturing specifically to produce complex orthopedic implants. As a result, the company has made great strides when it comes to the way that orthopedic implants are designed and produced.

On a recent episode of our DeviceTalks Tuesdays webinar — sponsored by GE Additive, Foster, and Siemens — Stryker executive Naomi Murray detailed the company’s two-decade additive manufacturing journey. Murray, the company’s director of advanced operations for additive technology, described how innovations utilizing 3D printing make healthcare better.

Here are four takeaways on how additive manufacturing is advancing orthope…

The advantages of laser-cut tube (LCT) catheters

Here’s how laser-cut tube (LCT) catheters compare to traditional catheters: the design process, functional advantages, test methods and cost comparisons.

DeviceTalks

The medical device community has a long history of using braided and coil-based catheter constructs. But these traditional constructs present multiple performance-based issues. “With the advent of the laser-cut tube capability we have at Resonetics, it’s opened up a lot of options for catheter manufacturing,” said Dave Rezac, VP of design and development services at the company, in a recent DeviceTalks Tuesdays webinar.

Kevin Hartke, Resonetics’ chief technical officer, joined Rezac in the Resonetics-sponsored webinar to discuss how their company studied the comparative performance of LCT versus traditional catheter constructs.

Go to our sister site Medical Tubing + Extrusion and read four takeaways on how LCT compares to the traditional catheter construct.

Provided to Medical Design…

The future of medtech is about connectivity and data

Here’s why medtech companies must embrace innovation, connectivity and disruption.

DeviceTalks

Healthcare must shift away from responding to acute episodes and focus on chronic and preventive care to provide better care, value, and population health. Data will inform the transition. Key questions include, “What does this mean for medtech? What role does medtech play in the future?”

The topic of innovation in healthcare — including devices, data, and disruption — was the focus of a recent episode of DeviceTalks Tuesdays, sponsored by S3 Connected Health.

Panelists included medical device experts Bill Betten, director of solutions – medtech for S3 Connected Health, and Michael Hill, PhD, retired VP of corporate science, technology and innovation at Medtronic and currently a partner at Science Innovation.

Here are five takeaways on the growing importance of data and disruption in medtech.

Get the full story on our s…

The future of medtech is about connectivity and data

Here’s why medtech companies must embrace innovation, connectivity and disruption.

DeviceTalks

Healthcare must shift away from responding to acute episodes and focus on chronic and preventive care to provide better care, value, and population health. Data will inform the transition. Key questions include, “What does this mean for medtech? What role does medtech play in the future?”

The topic of innovation in healthcare — including devices, data, and disruption — was the focus of a recent episode of DeviceTalks Tuesdays, sponsored by S3 Connected Health.

Panelists included medical device experts Bill Betten, director of solutions – medtech for S3 Connected Health, and Michael Hill, PhD, retired VP of corporate science, technology and innovation at Medtronic and currently a partner at Science Innovation.

Here are five takeaways on the growing importance of data and disruption in medtech:

1. Medical devices are becoming connected

Initially, “T…

How COVID-19 changed medical device clinical trials forever

The success of remote clinical trial oversight opens the door to hybrid approaches and creates new possibilities for the future of trials.

[Image from Unsplash]

DeviceTalks

Because of the pandemic, virtually overnight, all players involved in medical device clinical trials had to pivot to virtual monitoring to keep trials going. What impact did remote trial oversight have on the quality, safety, and costs of clinical trials? What are the implications for the future?

A panel of experts from across the clinical trial ecosystem discussed these topics on a recent episode of DeviceTalks Tuesdays, sponsored by IMARC.

Panelists included Hamish Baird, clinical research president at Remington-Davis; Brandy Chittester, president of IMARC Research; Xavier Lefebvre, global VP of medical and regulatory operations at Medtronic; and Dr. Eric Kolodziej, corporate VP and global head of quality and regulator…